New broad-spectrum vaccine to prevent cervical cancer induces strong responses in animals

Mice and rabbits immunized with a multimeric-L2 protein vaccine had robust antibody responses and were protected from infection when exposed to human papillomavirus (HPV) type 16 four months after vaccination, according to a new study published in the May 26 online issue of the Journal of the National Cancer Institute.

If you want to include this story in your blog, copy and paste this formatted text: